Shareholder Class Action Lawsuit Filed Against Revance Therapeutics, Inc. ATLANTA, Jan. 06, 2025 (GLOBE NEWSWIRE) A shareholder class action lawsuit has been filed against Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ: RVNC). The lawsuit alleges that Defendants made materially false and/or misleading statements, and/or failed to disclose material adverse facts about Revance’s business, operations,…

Investors Reminded of Class Action Lawsuit Against Zeta Global Holdings Corp. LOS ANGELES, CA / ACCESSWIRE / January 4, 2025 The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Zeta Global Holdings Corp. (“Zeta” or “the Company”) (NYSE:ZETA) for violations of 10(b) and 20(a) of the…

Class Action Lawsuit Filed Against Transocean Ltd. New York, Jan. 02, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Transocean Ltd. (“Transocean” or the “Company”) (NYSE: RIG) in the United States District Court for the Southern District…

Upgrade for Chewy Improving Customer Growth and Margins Recently, Wolfe Research analyst Shweta Khajuria upgraded Chewy to Outperform from Peer Perform with a price target of $42. This is exciting news for investors, as the firm highlighted four key points that led to the upgrade. Customer Growth One of the key reasons for the upgrade…

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In PACS Group Seek Legal Counsel Now If you suffered losses exceeding $50,000 in PACS Group between (a) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the…

Investigation of BioAge Labs, Inc. Delving into the Recent Events It is with a heavy heart that we bring you the news of Levi & Korsinsky commencing an investigation of BioAge Labs, Inc. This pharmaceutical company, listed on the NASDAQ under the ticker symbol BIOA, has come under scrutiny for potential violations of federal securities…